Jerald S. Cobbs
Corporate Officer/Principal presso Sanders Morris Harris Group Private Equity
Profilo
Jerald S.
Cobbs is currently a Principal at Sanders Morris Harris Group Private Equity since 1994.
He previously held positions as Chairman & Chief Executive Officer at Quantitative Diagnostics Laboratories, Inc., Independent Director at Bioject Medical Technologies, Inc. from 2012 to 2013, Managing Director at Signet Healthcare Partners LLC, and Chief Commercialization Officer at The Cancer Prevention & Research Institute of Texas.
Cobbs earned an MBA degree from the University of Houston.
Posizioni attive di Jerald S. Cobbs
| Società | Posizione | Inizio |
|---|---|---|
Sanders Morris Harris Group Private Equity
 Sanders Morris Harris Group Private Equity Investment ManagersFinance Headquartered in Houston, Sanders Morris Harris Group, Inc. (NADAQ: SMHG) invests in private equity through the SMH Private Equity Funds. | Corporate Officer/Principal | 01/01/1994 |
Precedenti posizioni note di Jerald S. Cobbs
| Società | Posizione | Fine |
|---|---|---|
The Cancer Prevention & Research Institute of Texas
 The Cancer Prevention & Research Institute of Texas BiotechnologyHealth Technology Cancer Prevention & Research Institute of Texas provides cancer research and prevention programs and services. It is the state agency mandated to create and expedite innovation in the area of cancer research and in enhancing the potential for a medical or scientific breakthrough in the prevention of cancer and cures for cancer. The company was founded in 2007 and is headquartered in Austin, TX. | Corporate Officer/Principal | 20/11/2012 |
Signet Healthcare Partners LLC
 Signet Healthcare Partners LLC Investment ManagersFinance Signet Healthcare Partners LLC (Signet Healthcare Partners) is a private equity/venture capital subsidiary of Sanders Morris Harris Group Private Equity founded in 1998. The firm is headquartered in New York. | Investitore di Private Equity | 31/12/2009 |
Quantitative Diagnostics Laboratories, Inc.
 Quantitative Diagnostics Laboratories, Inc. Medical/Nursing ServicesHealth Services Part of Roche Holding AG, Quantitative Diagnostics Laboratories, Inc. is an American company that operates a reference lab providing quantitative immunohistochemistry services to pathologists. The company is based in IL. Quantitative Diagnostics Laboratories was acquired by Ventana Medical Systems, Inc., part of Roche Holding AG from February 19, 2008 on April 04, 2000. | Presidente | - |
| BIOJECT MEDICAL TECHNOLOGIES INC. | Presidente | - |
Formazione di Jerald S. Cobbs
| University of Houston | Masters Business Admin |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 5 |
|---|---|
Bioject Medical Technologies, Inc.
 Bioject Medical Technologies, Inc. Medical SpecialtiesHealth Technology Bioject Medical Technologies, Inc. develops and manufactures needle-free injection therapy systems. Its products include Biojector 2000, Needle Free Injection System, ZetaJet, Drug Reconstitution System, and Needle-Free Vial Adapter. The company was founded in 1985 and is headquartered in Tigard, OR. | Health Technology |
Signet Healthcare Partners LLC
Signet Healthcare Partners LLC Investment ManagersFinance Signet Healthcare Partners LLC (Signet Healthcare Partners) is a private equity/venture capital subsidiary of Sanders Morris Harris Group Private Equity founded in 1998. The firm is headquartered in New York. | Finance |
Quantitative Diagnostics Laboratories, Inc.
Quantitative Diagnostics Laboratories, Inc. Medical/Nursing ServicesHealth Services Part of Roche Holding AG, Quantitative Diagnostics Laboratories, Inc. is an American company that operates a reference lab providing quantitative immunohistochemistry services to pathologists. The company is based in IL. Quantitative Diagnostics Laboratories was acquired by Ventana Medical Systems, Inc., part of Roche Holding AG from February 19, 2008 on April 04, 2000. | Health Services |
Sanders Morris Harris Group Private Equity
Sanders Morris Harris Group Private Equity Investment ManagersFinance Headquartered in Houston, Sanders Morris Harris Group, Inc. (NADAQ: SMHG) invests in private equity through the SMH Private Equity Funds. | Finance |
The Cancer Prevention & Research Institute of Texas
The Cancer Prevention & Research Institute of Texas BiotechnologyHealth Technology Cancer Prevention & Research Institute of Texas provides cancer research and prevention programs and services. It is the state agency mandated to create and expedite innovation in the area of cancer research and in enhancing the potential for a medical or scientific breakthrough in the prevention of cancer and cures for cancer. The company was founded in 2007 and is headquartered in Austin, TX. | Health Technology |
- Borsa valori
- Insiders
- Jerald S. Cobbs
